Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 17287148)

Published in Clin Gastroenterol Hepatol on February 06, 2007


Maya Gambarin-Gelwan1, Sanjiv V Kinkhabwala, Thomas D Schiano, Carol Bodian, Hsu-Chong Yeh, Walter Futterweit

Author Affiliations

1: Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, NY 10021, USA.

Articles citing this

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology (2009) 2.92

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22

Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am J Physiol Endocrinol Metab (2008) 1.20

Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci (2011) 1.16

Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev (2012) 1.05

Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol (2009) 1.02

NAFLD, Estrogens, and Physical Exercise: The Animal Model. J Nutr Metab (2011) 0.97

The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS One (2011) 0.91

Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol (2014) 0.89

Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J Gastroenterol (2014) 0.84

Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile. Fertil Steril (2013) 0.81

Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: retinol-binding protein 4 and ectopic fat deposition. Fertil Steril (2012) 0.79

Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol (2015) 0.79

An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive Cycle. Cell Rep (2016) 0.79

Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome. Obes Surg (2014) 0.78

Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis. Hepat Mon (2014) 0.78

Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls. Int J Endocrinol (2014) 0.78

Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome. World J Diabetes (2013) 0.77

Prevalence of hepatic steatosis in women with polycystic ovary syndrome. J Hum Reprod Sci (2013) 0.77

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome. Int J Endocrinol (2015) 0.76

Hepatic Steatosis is Common in Adolescents with Obesity and PCOS and Relates to De Novo Lipogenesis but not Insulin Resistance. Obesity (Silver Spring) (2016) 0.75

Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients. Int J Reprod Biomed (Yazd) (2016) 0.75

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. J Endocrinol Invest (2017) 0.75

Articles by these authors

(truncated to the top 100)

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology (2003) 3.87

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology (2007) 3.39

Adding emotional stressors to training in simulated cardiopulmonary arrest enhances participant performance. Med Educ (2010) 3.17

How time affects the risk of rupture in appendicitis. J Am Coll Surg (2006) 2.71

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48

Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol (2008) 2.16

Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08

TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol (2015) 1.99

Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol (2005) 1.79

The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol (2004) 1.74

Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol (2006) 1.69

Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68

Survival and risk of recidivism in methadone-dependent patients undergoing liver transplantation. Am J Transplant (2003) 1.60

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol (2008) 1.57

Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract (2008) 1.51

Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol (2004) 1.50

Optimizing selective cerebral perfusion: deleterious effects of high perfusion pressures. J Thorac Cardiovasc Surg (2008) 1.48

The fate of the distal aorta after repair of acute type A aortic dissection. J Thorac Cardiovasc Surg (2006) 1.47

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44

Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43

Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol (2011) 1.43

Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center. Ann Thorac Surg (2004) 1.43

Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. Eur J Gastroenterol Hepatol (2014) 1.40

Extubation in the operating room after congenital heart surgery in children. J Thorac Cardiovasc Surg (2008) 1.18

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl (2005) 1.13

Composite aortic root replacement in acute type A dissection: time to rethink the indications? Eur J Cardiothorac Surg (2005) 1.12

Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma. Clin Cancer Res (2002) 1.10

Preoperative arterial pulse pressure has no apparent association with perioperative mortality after lower extremity arterial bypass. Anesth Analg (2011) 1.09

Predictive model for postoperative delirium in cardiac surgical patients. Semin Cardiothorac Vasc Anesth (2010) 1.08

Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08

Pre-analytical errors: everything that happens to the specimen up to the point of testing. Fertil Steril (2002) 1.07

Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol (2008) 1.07

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocr Pract (2006) 1.07

Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05

Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01


Measuring the collateral network pressure to minimize paraplegia risk in thoracoabdominal aneurysm resection. J Thorac Cardiovasc Surg (2010) 0.98

A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril (2002) 0.96

The Relationship of Stress and Coping Methods to Adolescent Marijuana Use. Subst Abus (2001) 0.96

The Bentall procedure: is it the gold standard? A series of 597 consecutive cases. J Thorac Cardiovasc Surg (2010) 0.95

Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol (2002) 0.95

Outcome analysis of cirrhotic patients undergoing chest tube placement. Chest (2004) 0.94

Time and the risk of ruptured tubal pregnancy. Obstet Gynecol (2004) 0.92

Economic and safety implications of introducing fast tracking in congenital heart surgery. Circ Cardiovasc Qual Outcomes (2013) 0.92

Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation. Am J Transplant (2004) 0.91

Long-term integrity of teflon felt-supported suture lines in aortic surgery. Ann Thorac Surg (2005) 0.91

Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl (2006) 0.90

Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl (2009) 0.90

Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol (2005) 0.89

Obesity and the polycystic ovary syndrome. Med Clin North Am (2007) 0.89

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril (2011) 0.88

Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial. J Oral Maxillofac Surg (2010) 0.88


Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl (2014) 0.87

Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood (2003) 0.87

Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol (2011) 0.87

Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl (2006) 0.87

Preservation of spinal cord function after extensive segmental artery sacrifice: regional variations in perfusion. Ann Thorac Surg (2007) 0.84

Methotrexate therapy for primary biliary cirrhosis. Am J Gastroenterol (2003) 0.84

Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant (2012) 0.84

Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci (2013) 0.84

Risk of cardiovascular events in mothers of women with polycystic ovary syndrome. Endocr Pract (2008) 0.84

Avoidance of hemodilution during selective cerebral perfusion enhances neurobehavioral outcome in a survival porcine model. Eur J Cardiothorac Surg (2007) 0.83

Marked Differences in acute cellular rejection rates between living-donor and deceased-donor liver transplant recipients. Transplantation (2005) 0.83

Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery (2013) 0.83

Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn's disease. J Crohns Colitis (2012) 0.83

Polycystic ovary syndrome, depression, and affective disorders. Endocr Pract (2009) 0.82

Increasing hepatic arteriole wall thickness and decreased luminal diameter occur with increasing age in normal livers. J Hepatol (2011) 0.82

The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82

Inadequate visualization and reporting of ventricular function from transthoracic echocardiography after cardiac surgery. J Cardiothorac Vasc Anesth (2009) 0.82

Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl (2005) 0.82

Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol (2007) 0.82

Results of retransplantation for recurrent hepatitis C. Hepatology (2003) 0.82

Overdose with suicidal intent: ethical considerations for liver transplant programs. Liver Transpl (2011) 0.82

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82

Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation (2015) 0.82

Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assays. Am J Transplant (2004) 0.81

Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations. Cancer Cell Int (2013) 0.81

Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol (2012) 0.81

Optimal pH strategy for selective cerebral perfusion. Eur J Cardiothorac Surg (2005) 0.80

Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. Dig Dis Sci (2008) 0.80

FEM1A is a candidate gene for polycystic ovary syndrome. Gynecol Endocrinol (2005) 0.80

Factors affecting the decision to defer endotracheal extubation after surgery for congenital heart disease: a prospective observational study. Anesth Analg (2011) 0.80

Immunohistochemical visualization of histone H1 phosphorylation in squamous intraepithelial lesions of the gynecologic tract. Hum Pathol (2003) 0.79

Indication for surgery, the revised cardiac risk index, and 1-year mortality. Ann Vasc Surg (2011) 0.79

Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation (2007) 0.79

Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin. Endocr Pract (2012) 0.79

Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease. Hepatol Int (2010) 0.78

The efficacy of post-cardiopulmonary bypass dosing of vancomycin in cardiac surgery. Semin Cardiothorac Vasc Anesth (2010) 0.78

Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl (2007) 0.78

An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78

Adult live donor liver transplantation. Clin Liver Dis (2005) 0.78

Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods (2010) 0.78

Quantification of hepatic blood flow using a high-resolution phase-contrast MRI sequence with compressed sensing acceleration. AJR Am J Roentgenol (2015) 0.77

Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation. J Gastrointest Surg (2009) 0.77

Treating chronic hepatitis C in the primary care setting. Semin Liver Dis (2005) 0.77

Acute cellular rejection resulting in sinusoidal obstruction syndrome and ascites postliver transplantation. Transplantation (2011) 0.77